Telomir Pharmaceuticals reports Telomir-1 restores vision in AMD animal model

Telomir Pharmaceuticals, Inc.

Telomir-1 improved central vision response and motion detection in AMD zebrafish model.
Retinal layer regeneration observed: INL, GCL, IPL, OPL thickness increased.
Reactive oxygen species reduced ~50% vs. untreated; 15% mortality in controls vs. 0% in treated.
Results support continued advancement toward IND submission.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.